Original BioMedicals Co., Ltd. (6483.TWO)
TWD 11.75
(-4.08%)
TWD 11.75
(-4.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 43 Thousand | 107 Thousand | - | - | - |
| Cost of Revenue | 8000.00 | 12 Thousand | - | - | - |
| Gross Profit | 35 Thousand | 95 Thousand | - | - | - |
| Operating Expenses | 35 Thousand | 40.27 Million | 32.62 Million | 33.18 Million | 36.22 Million |
| Selling, General and Administrative Expenses | 34.58 Million | 17.36 Million | 11.92 Million | 11.68 Million | 12.57 Million |
| Research and Development Expenses | 24.71 Million | 22.91 Million | 20.74 Million | 22.05 Million | 26.36 Million |
| Other Expenses | - | 625 Thousand | - | - | - |
| Cost and Expenses | 59.3 Million | 40.28 Million | 32.62 Million | 33.18 Million | 36.22 Million |
| Operating Income | -59.26 Million | -39.08 Million | -32.66 Million | -33.74 Million | -38.93 Million |
| Interest Expense | 1.09 Million | 1.19 Million | - | - | - |
| Income Tax Expense | - | - | - | - | - |
| Earnings before Tax | -59.66 Million | -40.27 Million | -33.87 Million | -34.74 Million | -37.65 Million |
| Net Income | -59.66 Million | -40.27 Million | -33.87 Million | -34.74 Million | -37.65 Million |
| Earnings Per Share Basic | -1.21 | -0.86 | -0.81 | -1.26 | -1.57 |
| Earnings Per Share Diluted | -1.21 | -0.86 | -0.81 | -1.26 | -1.57 |
| Weighted Average Shares Outstanding | 49.34 Million | 46.83 Million | 41.62 Million | 27.57 Million | 23.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.34 Million | 46.83 Million | 41.62 Million | 27.62 Million | 23.91 Million |
| Gross Margin | 0.81 | 0.89 | - | - | - |
| EBIT Margin | -1158.74 | -291.06 | - | - | - |
| Profit Margin | -1387.47 | -376.42 | - | - | - |
| EBITDA | -49.82 Million | -31.19 Million | -27.42 Million | -25.25 Million | -28.59 Million |
| Earnings Before Tax Margin | -1378.19 | -365.24 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 43 Thousand | 21.5 Thousand | 21.5 Thousand | - |
| Cost of Revenue | 3.99 Million | - | 8000.00 | 4000.00 | 4000.00 | - |
| Gross Profit | -3.99 Million | - | 35 Thousand | 17.5 Thousand | 17.5 Thousand | - |
| Operating Expenses | 17.94 Million | 17.94 Million | 59.29 Million | 18.56 Million | 18.56 Million | 11.09 Million |
| Selling, General and Administrative Expenses | 11.34 Million | 11.34 Million | - | 11.67 Million | 11.67 Million | 5.61 Million |
| Research and Development Expenses | 6.6 Million | 6.6 Million | - | 6.87 Million | 6.87 Million | 5.47 Million |
| Other Expenses | - | - | -2000.00 | - | - | - |
| Cost and Expenses | 17.94 Million | 17.94 Million | 59.3 Million | 18.57 Million | 18.57 Million | 11.09 Million |
| Operating Income | -17.95 Million | -17.95 Million | -58.56 Million | -18.53 Million | -18.53 Million | -11.09 Million |
| Interest Expense | - | - | 1.09 Million | - | - | - |
| Income Tax Expense | - | - | - | - | - | - |
| Earnings before Tax | -17.15 Million | -17.15 Million | -59.66 Million | -18.59 Million | -18.59 Million | -11.23 Million |
| Net Income | -17.15 Million | -17.15 Million | -59.66 Million | -18.59 Million | -18.59 Million | -11.23 Million |
| Earnings Per Share Basic | -0.26 | -0.26 | - | -0.36 | -0.36 | -0.24 |
| Earnings Per Share Diluted | -0.26 | -0.26 | - | -0.36 | -0.36 | -0.24 |
| Weighted Average Shares Outstanding | 65.96 Million | 65.96 Million | 49.3 Million | 51.63 Million | 51.63 Million | 46.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 65.96 Million | 65.96 Million | 49.34 Million | 51.63 Million | 51.63 Million | 47.05 Million |
| Gross Margin | - | - | 0.81 | 0.81 | 0.81 | - |
| EBIT Margin | - | - | - | -808.72 | -808.72 | - |
| Profit Margin | - | - | -1387.47 | -865.02 | -865.02 | - |
| EBITDA | -15.87 Million | -15.87 Million | - | -17.38 Million | -17.38 Million | -9.93 Million |
| Earnings Before Tax Margin | - | - | -1361.93 | -862.07 | -862.07 | - |
1846
HLGN
0JWC
300775
3710
ROSSARI